Cagrilintide (CAS 1415456-99-3) – Wholesale & Research Grade
Cagrilintide, a peptide analog currently under investigation, has garnered interest in the field of metabolic research, particularly for its potential applications in weight management and obesity treatment. This compound is often studied in relation to its role as a glucagon-like peptide-1 (GLP-1) receptor agonist, which is crucial for regulating appetite and energy expenditure. As a result, cagrilintide may provide therapeutic benefits for individuals struggling with obesity and related metabolic disorders.
Mechanism of Action
The mechanism of action of cagrilintide involves the modulation of satiety signals in the central nervous system. By mimicking the regulatory effects of endogenous GLP-1, cagrilintide enhances insulin sensitivity and reduces food intake, leading to significant weight loss in clinical settings. This peptide's ability to influence glucose metabolism and appetite regulation positions it as a promising candidate for treating obesity and type 2 diabetes.
Solubility and Storage
Cagrilintide exhibits solubility in aqueous solutions, making it suitable for various formulations in pharmaceutical applications. For optimal stability, it should be stored in a cool, dry place, away from direct light and moisture. It is essential to follow proper handling procedures to maintain the integrity of the compound, especially when preparing solutions for research or clinical use.
Future Research Directions
- Exploration of combination therapies involving cagrilintide and other metabolic agents to enhance efficacy and patient outcomes.
- Investigation into the long-term effects of cagrilintide on weight maintenance and metabolic health.
- Development of novel delivery systems to improve the bioavailability and patient compliance of cagrilintide treatments.
As research progresses, cagrilintide remains a focal point in the quest for innovative strategies to combat obesity and its associated health challenges, underscoring its potential as a transformative therapeutic agent.
| CAS Number | 1415456-99-3 |
|---|---|
| Formula | C194H312N54O59S2 |
| Mol. Weight | 4409 g/mol |
| IUPAC Name | 20-[[(1S)-4-[[(2S)-6-amino-1-[[(4R,7S,10S,13S,16S,19R)-4-[[(2S)-1-[[(2S,3R)-1... |
| Grade | HPLC ≥98% |
Synthesis & Storage
Cagrilintide is supplied as a lyophilized powder to ensure stability during transit.
For long-term storage of CAS 1415456-99-3, we recommend maintaining at -20°C.
Researchers must reconstitute this peptide with bacteriostatic water or sterile solvent only when ready for use.
Quality Control: All batches undergo rigorous HPLC purity testing (≥98%) prior to dispatch from our USA fulfillment center.